Publications by authors named "J C Barbare"

Claim this Profile
R
Real-life data on hepatocellular carcinoma in the French prospective CHIEF cohort in the era of immunotherapy.
Eric Nguyen-Khac, Philippe Merle, Hajer Ben Khadhra, Amaddeo Giuliana, Thomas Decaens, Jean Claude Barbare

Eur J Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, AFEF, SIAD, SFR/FRI).
Jean Frédéric Blanc, Audrey Debaillon-Vesque, Gaël Roth, Jean Claude Barbare, Anne Sophie Baumann

Clin Res Hepatol Gastroenterol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographical Disparities of Outcomes of Hepatocellular Carcinoma in France: The Heavier Burden of Alcohol Compared to Hepatitis C.
Charlotte E Costentin, Philippe Sogni, Bruno Falissard, Jean-Claude Barbare, Noelle Bendersky

Dig Dis Sci· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Idarubicin-loaded Beads for Chemoembolization of Hepatocellular Carcinoma: The IDASPHERE II Single-Arm Phase II Trial.
Boris Guiu, Patrick Chevallier, Eric Assenat, Emilie Barbier, Philippe Merle, Jean-Claude Barbare

Radiology· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early decrease in serum amphiregulin or vascular endothelial growth factor levels predicts sorafenib efficacy in hepatocellular carcinoma.
Corinne Godin, Sandra Bodeau, Zuzana Saidak, Christophe Louandre, Catherine François, Jean-Claude Barbare

Oncol Rep· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis